National Board of Examinations Journal of Medical Sciences (NBEJMS)

Home About Us Editioral Board Previous Issues Article Submission Guidelines for Authors Online ISSN: 2583-7524 Contact Us Abstract and Indexing Registration
एनबीईएमएस

March 2026, Volume 4, Issue 3

Author
S. Sanjeev Kumar, R. Ashok Kumar and R. Vinoth Kumar



Abstract
Background: Erectile dysfunction (ED) refers to the ongoing difficulty in achieving and sustaining an erection adequate for satisfying sexual activity. Globally, a key concern involves individuals bypassing medical professionals to acquire ED medications (EDMs) without prescriptions. Objective: This study evaluates erectile function in a sample of local physicians, examines the psychological consequences of recreational EDM use, and compares erectile function across user categories. Methods: We conducted a cross-sectional survey exclusively among physicians at various hospital around Pondicherry. Participants completed a custom questionnaire covering demographics, sexual history, EDM usage, sexual satisfaction levels, and the validated International Index of Erectile Function (IIEF). Results: The study of 400 physicians showed 75.5% were non-users of oral erectile dysfunction medications (EDMs), with 19.5% using them recreationally. Recreational use was more common in younger and mid-career physicians, predominantly acquired over-the-counter, and mainly for enhancing erection strength, self-confidence, or partner satisfaction. Cialis (Tadalafil) and Snafi were the most commonly used brands. Most users reported occasional use and minor adverse effects, with post-use satisfaction notably higher than pre-use. Overall, recreational EDM use did not significantly impair erectile function compared to non-users, though prescribed users had lower IIEF scores. Conclusion: A substantial number of healthy, sexually active men turn to EDMs recreationally to enhance performance. Recreational EDM use can negatively affect psychological dimensions of sexual health. Our findings reveal EDM misuse among physicians, supporting the need to classify these drugs as prescription-only, dispensed by licensed healthcare providers.